AAV2-mediated interleukin-12 in the treatment of malignant brain tumor through activation of NK cells
博士 === 慈濟大學 === 醫學研究所 === 98 === Interleukin-12 has been elucidated as a powerful anti-cancer factor in pre-clinical research. However, the obstacles of this modality that emerged from human clinical trails included the toxicity of repeated large dose administration and short effective duration. The...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Online Access: | http://ndltd.ncl.edu.tw/handle/23837381031271592971 |